ANIK: Anika Therapeutics, Inc. - Summary | Jitta

Anika Therapeutics, Inc.

NASDAQ:ANIK

Price
$39.23
Loss Chance
49.7%
4.45JITTA SCORE
216.80%Over Jitta Line
Jitta Ranking
308 / 935
2,738 / 4,291
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (30)
Recent Business Performance (29)
Financial Strength (93)
Return to Shareholders (32)
Competitive Advantage (42)
Jitta Signs
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
Revenue and EarningEarning decline from 2014-2019
Operating MarginInconsistent
Recent Business PerformanceEarning decline 109.06% in the last quarter (yoy)
SG&A to SalesIncreasing Every Year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.45
216.80%
1.46
145.36%
2.31
337.26%
Biotechnology
6.53
47.97%
4.05
100.00%
3.21
63.51%
COMPANY DESCRIPTION
Anika Therapeutics, Inc., together with its subsidiaries, operates as an integrated joint preservation, restoration, and regenerative solutions company in the United States, Europe, and internationally. The company’s lead products include HYALOMATRIX for the treatment of skin wounds, such as pressure ulcers, diabetic foot ulcers, and deep second-degree burns; and MEROGEL, a woven fleece nasal packing. Its joint pain management products comprise MONOVISC, ORTHOVISC, and CINGAL that are used as hyaluronic acid (HA) based viscosupplements to treat osteoarthritis pain in humans; and HYVISC, a HA-based treatment for equine osteoarthritis pain. In addition, the company offers HYALOFAST, a HYAFF-based support for human bone marrow mesenchymal stem cells used for cartilage regeneration and adjunct for microfracture surgery; and Tactoset, a HA-enhanced bone repair therapy to treat insufficiency fractures. Further, it provides ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; joint surface implant and preservation solutions for knee, shoulder, hip, ankle, wrist, and toe to treat upper and lower orthopedic conditions caused by trauma, injury, and arthritic disease; and surgical implant and instrumentation solutions that are used by surgeons to repair and reconstruct damaged ligaments and tendons. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.